4
Changes in Ownership
NOVAVAX INC Filed Acc 0001209191-21-058076
President, R&D sold 2,083 shares at an average $234.43 ($488,315)
- President, R&D gave up 648 shares (to pay taxes)
- President, R&D acquired 3,460 shares (option exercise)
- President, R&D returned 36 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Glenn Gregory M · President, R&D
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-27 | Exercise or conversion : show line 1 in the form | +2,083 | $5.95 | $12,394 | 6,144 | D |
| 2021-09-27 | Sale : show line 2 in the form | −57 | $228.12 | $13,003 | 6,087 | D |
| 2021-09-27 | Sale : show line 3 in the form | −225 | $229.99 | $51,748 | 5,862 | D |
| 2021-09-27 | Sale : show line 4 in the form | −272 | $231.07 | $62,850 | 5,590 | D |
| 2021-09-27 | Sale : show line 5 in the form | −318 | $232.00 | $73,775 | 5,272 | D |
| 2021-09-27 | Sale : show line 6 in the form | −262 | $233.24 | $61,108 | 5,010 | D |
| 2021-09-27 | Sale : show line 7 in the form | −217 | $233.87 | $50,750 | 4,793 | D |
| 2021-09-27 | Sale : show line 8 in the form | −203 | $235.10 | $47,726 | 4,590 | D |
| Open-market sales · 2,083 sh · avg $234.43 · $488,315 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-09-27 | Exercise or conversion : show line 18 in the form Stock Option (Right to Buy) | −2,083 | $5.95 | 2029-09-26 | 2,083 | 50,001 | D |
| 2021-09-27 | Exercise or conversion : show line 19 in the form Stock Appreciation Right | −1,377 | $5.95 | 2029-09-26 | 1,377 | 33,051 | D |
Loading xslF345X03/doc4.xml…